16:17 EST Regenxbio (RGNX) files $300M mixed securities shelf
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGNX:
- RegenXBio’s Strategic Manufacturing and Commercial Readiness Justifies Buy Rating and $34 Price Target
- RegenXBio’s Strategic Manufacturing Edge and Market Position Justify Buy Rating
- RegenXBio Inc. Earnings Call: Positive Progress Amid Challenges
- Regenxbio price target raised to $25 from $24 at Morgan Stanley
- REGENXBIO Reports Q3 2025 Financial and Operational Progress